Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Plasma cell myeloma refractory

Recruiting

InvestigationalNo placebo

JNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Chronic myeloid leukaemia

Recruiting

Registered drugNo placebo

Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bosutinib

Contact Research Centre

Asthma

Recruiting

Investigational

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational

Greece

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Fallopian tube cancer+2

Recruiting

Registered drugNo placebo

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Pneumonia bacterial

Recruiting

Registered drug

A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Saline

Contact Research Centre

Graves' disease

Recruiting

InvestigationalNo placebo

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

IgA nephropathy

Recruiting

InvestigationalNo placebo

Long-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:ZIGAKIBART

Contact Research Centre

Renal cell carcinoma

Recruiting

Registered drug

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Pulmonary arterial hypertension

Recruiting

Investigational

A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

Investigational

Greece

Participants:18–64 years · 65+ years

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drugNo placebo

A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Find therapies in clinical trials near you – page 9

1 084 trials match your criteria

Plasma cell myeloma refractory

JNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments

Chronic myeloid leukaemia

Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Asthma

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Small cell lung cancer

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Fallopian tube cancer+2

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Pneumonia bacterial

A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.

Graves' disease

Long-Term Study of Imeroprubart in Adults With Graves' Disease

IgA nephropathy

Long-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials

Renal cell carcinoma

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Pulmonary arterial hypertension

A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

Ovarian cancer

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Plasma cell myeloma refractory

A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.